Search bioRxiv⌕ Search

Biology subjects

Gowda, A. M.

Publications and source records attributed to Gowda, A. M..

3 recordsLinked to original sources

RyR2-Mediated Ca2+ Leak Drives Progressive Arrhythmogenic Cardiomyopathy

Background Abnormal sarcoplasmic reticulum (SR) Ca2+ release through ryanodine receptor 2 (RyR2) is a well-established mechanism of ventricular arrhythmias. Whether persistent RyR2 dysfunction can also initiate the structural remodeling characteristic of arrhythmogenic cardiomyopathy (ACM) remains unknown. We tested the hypothesis that chronic RyR2-mediated Ca2+ leak is sufficient to couple electrical instability to progressive cardiomyopathy. Methods We generated a rabbit carrying the severe gain-of-function RyR2-V2475F mutation and characterized disease progression using longitudinal cardiac phenotyping, continuous electrocardiographic monitoring, cellular electrophysiology and Ca2+ imaging, histopathology, biochemical analyses, and single-nucleus RNA sequencing (snRNA-seq). Therapeutic potential was evaluated by continuous treatment with the selective RyR2 inhibitor ent-verticilide for two months. Results RyR2-V2475F rabbits developed spontaneous ventricular tachyarrhythmias, sudden cardiac death, and progressive right ventricular (RV)-dominant fibrofatty cardiomyopathy recapitulating major features of human ACM. Malignant ventricular arrhythmias preceded overt structural remodeling and were associated at the cellular level with early spontaneous Ca2+ release and early afterdepolarizations. Early disease was characterized by remodeling of excitation-contraction coupling with preserved SR Ca2+ load and contractile function despite RyR2 dysfunction; upon disease progression, these compensatory changes were accompanied by SR Ca2+ depletion, impaired RV contractility and reduced left ventricular filling. Single-nucleus transcriptomics identified early fibroblast expansion and predicted cardiomyocyte-centered paracrine signaling before advanced fibrofatty infiltration. Cardiomyocytes also exhibited an altered lipid-metabolic transcriptome and intracellular lipid accumulation, accompanied by enhanced mitochondrial Ca2+ uptake. Selective RyR2 inhibition markedly reduced ventricular tachycardia burden and preserved RV contraction and LV filling during disease progression. Conclusions Severe RyR2 gain-of-function can lead to both malignant ventricular arrhythmias and progressive arrhythmogenic cardiomyopathy in a large-animal model, establishing persistent intracellular Ca2+ dysregulation as a mechanistic link between electrical and structural heart disease. The ability of selective RyR2 inhibition to suppress arrhythmias and preserve cardiac function identifies RyR2 as a potentially actionable therapeutic target in arrhythmogenic cardiomyopathy.

physiology↗

Excitation-contraction coupling plasticity is revealed upon RyR2 depletion in adult mouse ventricular myocytes

Ryanodine receptor 2 (RyR2) is central to cardiac excitation-contraction coupling (ECC), translating electrical signals into sarcoplasmic reticulum (SR) Ca2+ release and mechanical contraction. Although constitutive deletion of RyR2 is lethal, adult hearts can withstand a significant reduction in RyR2 expression without overt ECC dysfunction. We hypothesized that ECC possesses intrinsic homeostatic plasticity that rapidly adapts to acute RyR2 loss to maintain cardiac performance. Using an adult tamoxifen-inducible RyR2 conditional knockout (RyR2cKO) mouse model, we evaluated cardiac structure, electrophysiology, and intracellular Ca2+ dynamics. RyR2cKO mice survived for weeks with <10% residual RyR2 protein expression. In vivo echocardiography and electrocardiography revealed normal cardiac structure and function. Confocal Ca2+ imaging in intact hearts and isolated ventricular myocytes showed preserved Ca2+ transient (CaT) amplitude but slower release kinetics and elevated SR load. Simultaneous patch-clamp and confocal Ca2+ imaging established that L-type Ca2+ current (ICa) and ECC gain were maintained in RyR2cKO myocytes. Expression of CaV1.2, NCX, and phospholamban remained unchanged, whereas SERCA2a, IP3 receptor, and VMP1 levels decreased. Pharmacological inhibition of IP3 receptors did not suppress CaT, ruling out alternative SR channel compensation. These findings reveal remarkable intrinsic ECC plasticity, where high RyR2 channel reserve, elevated SR Ca2+ load, and CaT autoregulation collectively maintain cardiac Ca2+ cycling and contractile function despite profound RyR2 depletion.

physiology↗

Rad and Phospholamban are Key Drivers of the Ventricular Adrenergic Response and Stress-Induced Arrhythmia

The adrenergic response is a fundamental mechanism that regulates heart rate (chronotropy), cardiac contractility (inotropy) and relaxation (lusitropy). Adrenergic stress is also a recognized trigger of arrhythmia in disease. Yet, our understanding of the underlying molecular basis remains incomplete. Protein kinase A (PKA) and the calcium/calmodulin-dependent kinase II (CaMKII) phosphorylate multiple targets proposed to participate in the adrenergic response, including the GTP-binding protein Rad, phospholamban (PLB) and ryanodine receptor 2 (RyR2). Here we demonstrate that phosphorylation of both Rad and PLB is necessary for inotropy and lusitropy. We show that changes in cardiac contractility and relaxation are primarily dependent on intracellular calcium handling. Finally, we report that Rad and PLB control stress-induced arrhythmogenesis, despite the phosphorylation of other pro-arrhythmic targets. We have identified the essential molecular components of the adrenergic response, resolving a long-standing debate in cardiac excitation-contraction coupling and refining current models of sympathetic regulation in health and disease.

physiology↗